Pharmaceutical manufacturer for Chloroquine phosphate

Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has eight manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc. Natco family currently consists of around 4500 employees, we are consistently ranked among fastest growing pharmaceutical companies in India. Natco is well recognized for its innovation in Pharmaceutical R&D.

Suven Pharmaceuticals Limited, an organization established in November 2018, has transformed into a Wholly Owned Subsidiary of Suven Life Sciences Limited, effective from February 2019. Suven Life Sciences Limited, following the Board meeting on February 5, 2019, declared the demerger of Suven Life Sciences Limited into two parts: Suven Life Sciences Limited, the demerged entity, will persist in pioneering research dedicated to Central Nervous System (CNS) disorders to address significant unmet medical needs worldwide. Suven Pharmaceuticals Limited, the resulting entity, will carry on the CRAMS business operations.

Our company is engaged in the manufacturing of active pharmaceutical ingredients in Russia and is in the process of finalizing the construction of our facility in Austria dedicated to the production of pharmaceutical drugs. The active pharmaceutical ingredients are derived using the purest fresh water sourced from a reservoir and powered by sustainable electricity from the Novosibirsk hydroelectric power station